5428-00-2

Usage

Uses

Used in Pharmaceutical Industry:
Bromo(cyclohexyl)acetic acid is used as a building block in organic synthesis for the production of pharmaceuticals due to its wide range of reactivity and versatility in forming different molecular structures.
Used in Agrochemical Industry:
Bromo(cyclohexyl)acetic acid is used in the production of agrochemicals due to its wide range of reactivity and versatility in forming different molecular structures.
Used in Drug Development:
Bromo(cyclohexyl)acetic acid is used as a potential candidate for drug development for various medical applications due to its anti-inflammatory and analgesic properties.

Upstream product

• 5292-21-7 Cyclohexylacetic acid 

Downstream Products

• 287392-16-9 2-{[4-(2-Butynyloxy)phenyl]sulfinyl}-2-cyclohexyl-N-hydroxyacetamide 
• 287392-15-8 2-{[4-(2-Butynyloxy)phenyl]sulfanyl}-2-cyclohexyl-N-hydroxyacetamide 
• 287393-01-5 ethyl-{[4-(2-butynyloxy)phenyl]sulfanyl}(cyclohexyl)acetate 
• 287393-02-6 {[4-(2-butynyloxy)phenyl]sulfanyl}(cyclohexyl)acetic acid 
• 287393-00-4 ethyl cyclohexyl [4-(hydroxyphenyl)sulfanyl]acetate 
• 287392-99-8 cyclohexyl [4-(hydroxyphenyl)sulfanyl]acetic acid 

Relevant academic research and scientific papers

Synthesis and structure-activity relationships of 4-alkynyloxy phenyl sulfanyl, sulfinyl, and sulfonyl alkyl hydroxamates as tumor necrosis factor-α converting enzyme and matrix metalloproteinase inhibitors

A series of 4-alkynyloxy phenyl sulfanyl, sulfinyl and sulfony alkyl and piperidine-4-carboxylic acid hydroxamides were synthesized. Their structure-activity relationships, against tumor necrosis factor-α (TACE) and matrix metalloproteinase (MMP) inhibito

Alkynyl containing hydroxamic acid compounds as matrix metalloproteinase and tace inhibitors

Compounds of the formula are useful in treating disease conditions mediated by TNF-α, such as rheumatoid arthritis, osteoarthritis, sepsis, AIDS, ulcerative colitis, multiple sclerosis, Crohn's disease and degenerative cartilage loss.